Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating BR1015 in combination therapy for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BR1015

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED